These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 9464547)

  • 21. p53 oligomerization and DNA looping are linked with transcriptional activation.
    Stenger JE; Tegtmeyer P; Mayr GA; Reed M; Wang Y; Wang P; Hough PV; Mastrangelo IA
    EMBO J; 1994 Dec; 13(24):6011-20. PubMed ID: 7813439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The proliferation-associated early response gene p22/PRG1 is a novel p53 target gene.
    Schäfer H; Trauzold A; Sebens T; Deppert W; Fölsch UR; Schmidt WE
    Oncogene; 1998 May; 16(19):2479-87. PubMed ID: 9627114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel mechanism for p53 to regulate its target gene ECK in signaling apoptosis.
    Jin YJ; Wang J; Qiao C; Hei TK; Brandt-Rauf PW; Yin Y
    Mol Cancer Res; 2006 Oct; 4(10):769-78. PubMed ID: 17050670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 'Gain of function' phenotype of tumor-derived mutant p53 requires the oligomerization/nonsequence-specific nucleic acid-binding domain.
    Lányi A; Deb D; Seymour RC; Ludes-Meyers JH; Subler MA; Deb S
    Oncogene; 1998 Jun; 16(24):3169-76. PubMed ID: 9671396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein interactions at the carboxyl terminus of p53 result in the induction of its in vitro transactivation potential.
    Mundt M; Hupp T; Fritsche M; Merkle C; Hansen S; Lane D; Groner B
    Oncogene; 1997 Jul; 15(2):237-44. PubMed ID: 9244359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple response elements and differential p53 binding control Perp expression during apoptosis.
    Reczek EE; Flores ER; Tsay AS; Attardi LD; Jacks T
    Mol Cancer Res; 2003 Dec; 1(14):1048-57. PubMed ID: 14707288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formation and properties of hairpin and tetraplex structures of guanine-rich regulatory sequences of muscle-specific genes.
    Yafe A; Etzioni S; Weisman-Shomer P; Fry M
    Nucleic Acids Res; 2005; 33(9):2887-900. PubMed ID: 15908587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Introduction of p16INK4a inhibits telomerase activity through transcriptional suppression of human telomerase reverse transcriptase expression in human gliomas.
    Saito M; Nakagawa K; Hamada K; Hirose S; Harada H; Kohno S; Nagato S; Ohnishi T
    Int J Oncol; 2004 May; 24(5):1213-20. PubMed ID: 15067344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site.
    Takimoto R; El-Deiry WS
    Oncogene; 2000 Mar; 19(14):1735-43. PubMed ID: 10777207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histone deacetylase 5 is not a p53 target gene, but its overexpression inhibits tumor cell growth and induces apoptosis.
    Huang Y; Tan M; Gosink M; Wang KK; Sun Y
    Cancer Res; 2002 May; 62(10):2913-22. PubMed ID: 12019172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements.
    Campomenosi P; Monti P; Aprile A; Abbondandolo A; Frebourg T; Gold B; Crook T; Inga A; Resnick MA; Iggo R; Fronza G
    Oncogene; 2001 Jun; 20(27):3573-9. PubMed ID: 11429705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-affinity binding of tumor-suppressor protein p53 and HMGB1 to hemicatenated DNA loops.
    Stros M; Muselíková-Polanská E; Pospísilová S; Strauss F
    Biochemistry; 2004 Jun; 43(22):7215-25. PubMed ID: 15170359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alternative pathway of transcriptional induction of p21WAF1/Cip1 by cyclosporine A in p53-deficient human glioblastoma cells.
    Zupanska A; Adach A; Dziembowska M; Kaminska B
    Cell Signal; 2007 Jun; 19(6):1268-78. PubMed ID: 17321721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The second BRCT domain of BRCA1 proteins interacts with p53 and stimulates transcription from the p21WAF1/CIP1 promoter.
    Chai YL; Cui J; Shao N; Shyam E; Reddy P; Rao VN
    Oncogene; 1999 Jan; 18(1):263-8. PubMed ID: 9926942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physical and functional interactions between members of the tumour suppressor p53 and the Sp families of transcription factors: importance for the regulation of genes involved in cell-cycle arrest and apoptosis.
    Koutsodontis G; Vasilaki E; Chou WC; Papakosta P; Kardassis D
    Biochem J; 2005 Jul; 389(Pt 2):443-55. PubMed ID: 15790310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular smooth muscle cell-specific regulation of cyclin-dependent kinase inhibitor p21(WAF1/Cip1) transcription by Sp1 is mediated via distinct cis-acting positive and negative regulatory elements in the proximal p21(WAF1/Cip1) promoter.
    Kavurma MM; Khachigian LM
    J Cell Biochem; 2004 Nov; 93(5):904-16. PubMed ID: 15389873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human smooth muscle alpha-actin gene is a transcriptional target of the p53 tumor suppressor protein.
    Comer KA; Dennis PA; Armstrong L; Catino JJ; Kastan MB; Kumar CC
    Oncogene; 1998 Mar; 16(10):1299-308. PubMed ID: 9546431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of an ING1 growth regulator in transcriptional activation and targeted histone acetylation by the NuA4 complex.
    Nourani A; Doyon Y; Utley RT; Allard S; Lane WS; Côté J
    Mol Cell Biol; 2001 Nov; 21(22):7629-40. PubMed ID: 11604499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element.
    Zambetti GP; Bargonetti J; Walker K; Prives C; Levine AJ
    Genes Dev; 1992 Jul; 6(7):1143-52. PubMed ID: 1628822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mouse p53 represses the rat brain creatine kinase gene but activates the rat muscle creatine kinase gene.
    Zhao J; Schmieg FI; Simmons DT; Molloy GR
    Mol Cell Biol; 1994 Dec; 14(12):8483-92. PubMed ID: 7969181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.